TOBRABACT

This brand name is authorized in Spain, France, South Africa

Active ingredients

The drug TOBRABACT contains one active pharmaceutical ingredient (API):

1 Tobramycin UNII VZ8RRZ51VK - TOBRAMYCIN

Tobramycin is an aminoglycoside antibiotic produced by Streptomyces tenebrarius. It acts primarily by disrupting protein synthesis leading to altered cell membrane permeability, progressive disruption of the cell envelope and eventual cell death. It is bactericidal at concentrations equal to or slightly greater than inhibitory concentrations. Read about Tobramycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
TOBRABACT Eye drops, solution	Web Search	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AA12	Tobramycin	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 64350
Country: FR	Base de données publique des médicaments	Identifier(s): 69240211
Country: ZA	Health Products Regulatory Authority	Identifier(s): 37/15.1/0082